OXFORD, England--(BUSINESS WIRE)--ProImmune Ltd., a leader in services for understanding immune responses, has today launched ProPresent™, a new assay service for the direct identification of the portions of a protein (antigen) that are made visible to T cells by the immune system. The assay identifies antigens that are displayed to T cells by Class II HLA molecules on dendritic cells, which is the most direct way for measuring antigen processing and presentation. ProPresent is the only commercially available service for this purpose and will accelerate drug and vaccine development programs where understanding detailed immune responses to a new compound is essential.
